FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

427881007: Product containing dolasetron in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3709669012 Dolasetron-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3709670013 Product containing dolasetron in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4369241000005116 dolasetron til parenteral anvendelse da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron-containing product in parenteral dose form Is a Product containing dolasetron (medicinal product) true Inferred relationship Some
Dolasetron-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dolasetron (substance) true Inferred relationship Some 1
Dolasetron-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Dolasetron-containing product in parenteral dose form Is a Product manufactured as parenteral dose form (product) true Inferred relationship Some
Dolasetron-containing product in parenteral dose form Plays role Antiemetic therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 0,625 ml Is a False Dolasetron-containing product in parenteral dose form Inferred relationship Some
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml Is a False Dolasetron-containing product in parenteral dose form Inferred relationship Some
Dolasetron mesilate 20 mg powder for solution for injection ampoule Is a False Dolasetron-containing product in parenteral dose form Inferred relationship Some
Dolasetron only product in parenteral dose form Is a True Dolasetron-containing product in parenteral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start